본문 바로가기
KERD
논문KCI 등재

Induction of tolerance against the arthritogenic antigen with type-II collagen peptide-linked soluble MHC class II molecules

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류화학

초록

In murine collagen-induced arthritis (CIA), self-reactive T cells can recognize peptide antigens derived from type-II collagen (CII). Activation of T cells is an important mediator of autoimmune diseases. Thus, T cells have become a focal point of study to treat autoimmune diseases. In this study, we evaluated the efficacy of recombinant MHC class II molecules in the regulation of antigen-specific T cells by using a self peptide derived from CII (CII260-274; IAGFKGEQGPKGEPG) linked to mouse I-Aq in a murine CIA model. We found that recombinant I-Aq/CII260-274 molecules could be recognized by CII-specific T cells and inhibit the same T cells in vitro. Furthermore, the development of CIA in mice was successfully prevented by in vivo injection of recombinant I-Aq/CII260-274 molecules. Thus, treatment with recombinant soluble MHC class II molecules in complex with an immunodominant self-peptide might offer a potential therapeutic for chronic inflammation in autoimmune disease such as rheumatoid arthritis.

Abstract

In murine collagen-induced arthritis (CIA), self-reactive T cells can recognize peptide antigens derived from type-II collagen (CII). Activation of T cells is an important mediator of autoimmune diseases. Thus, T cells have become a focal point of study to treat autoimmune diseases. In this study, we evaluated the efficacy of recombinant MHC class II molecules in the regulation of antigen-specific T cells by using a self peptide derived from CII (CII260-274; IAGFKGEQGPKGEPG) linked to mouse I-Aq in a murine CIA model. We found that recombinant I-Aq/CII260-274 molecules could be recognized by CII-specific T cells and inhibit the same T cells in vitro. Furthermore, the development of CIA in mice was successfully prevented by in vivo injection of recombinant I-Aq/CII260-274 molecules. Thus, treatment with recombinant soluble MHC class II molecules in complex with an immunodominant self-peptide might offer a potential therapeutic for chronic inflammation in autoimmune disease such as rheumatoid arthritis.

참고문헌 (31)

  1. Imboden JB, "The immunopathogenesis of rheumatoid arthritis", Annu Rev Pathol, 4, pp.417~434 (2009)
  2. Firestein GS, "The T cell cometh: interplay between adaptive immunity, cytokine networks in rheumatoid arthritis", J Clin Invest, 114, pp.471~474 (2004)
  3. Courtenay JS, "Immunisation against heterologous type II collagen induces arthritis in mice", Nature, 283, pp.666~668 (1980)
  4. Zanelli E, "Could HLA-DRB1 be the protective locus in rheumatoid arthritis?", Immunol Today, 16, pp.274~278 (1995)
  5. Trentham DE, "Autoimmunity to type II collagen an experimental model of arthritis", J Exp Med, 146, pp.857~868 (1977)
  6. Mauri C, "Relationship between Th1", Th2 cytokine patterns, the arthritogenic response in collagen-induced arthritis, 1996, pp.26, 1511~1518
  7. Ortmann RA, "Susceptibility to collagen-induced arthritis: cytokine-mediated regulation", Clin Immunol, 98, pp.109~118 (2001)
  8. Miossec P, "Th1", Th2 cytokine balance in arthritis, 1997, pp.40, 2105~2115
  9. Burrows GG, "Systemic immunomodulation of autoimmune disease using MHC-derived recombinant TCR ligands", Curr Drug Targets Inflamm Allergy, 4, pp.185~193 (2005)
  10. Quill H, "Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness", J Immunol, 138, pp.3704~3712 (1987)
  11. Schwartz RH, "Models of T cell anergy: is there a common molecular mechanism?", J Exp Med, 184, pp.1~8 (1996)
  12. Appel H, "Anergy induction by dimeric TCR ligands", J Immunol, 166, pp.5279~5285 (2001)
  13. Smith-Garvin JE, "T cell activation", Annu Rev Immunol, 27, pp.591~619 (2009)
  14. DeFord-Watts LM, "The CD3 zeta subunit contains a phosphoinositide-binding motif that is required for the stable accumulation of TCR-CD3 complex at the immunological synapse", J Immunol, 186, pp.6839~6847 (2011)
  15. Appleman LJ, "T cell anergy, costimulation", Immunol Rev, 192, pp.161~180 (2003)
  16. Rhode PR, "Single-chain MHC class II molecules induce T cell activation, apoptosis", J Immunol, 157, pp.4885~4891 (1996)
  17. Nag B, "Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells", Cell Immunol, 170, pp.25~33 (1996)
  18. Hurlin PJ, "Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation", EMBO J, 15, pp.2030~ (1996)
  19. Zhang Y, "Synergistic effects of interleukin-1beta, interleukin-17A antibodies on collagen-induced arthritis mouse model", Int Immunopharmacol, 15, pp.199~205 (2013)
  20. Nakajima A, "Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis", J Clin Invest, 107, pp.1293~1301 (2001)
  21. Morita Y, "Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis", J Clin Invest, 107, pp.1275~1284 (2001)
  22. Savage P, "Expansion of CD8+ cytotoxic T cells in vitro, in vivo using MHC class I tetramers", Tumour Biol, 28, pp.70~76 (2007)
  23. Huan J, "MHC class II derived recombinant T cell receptor ligands protect DBA", 1LacJ mice from collagen-induced arthritis, 2008, pp.180, 1249~1257
  24. Mealey RH, "Early detection of dominant Env-specific, subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I", peptide tetrameric complexes, 2005, pp.339, 110~126
  25. Offner H, "Recombinant T cell receptor ligands: immunomodulatory, neuroprotective, neuroregenerative effects suggest application as therapy for multiple sclerosis", Rev Neurosci, 19, pp.327~339 (2008)
  26. Huan J, "Monomeric recombinant TCR ligand reduces relapse rate, severity of experimental autoimmune encephalomyelitis in SJL", J mice through cytokine switch, 2004, pp.172, 4556~4566
  27. Kotzin BL, "Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis", Proc Natl Acad Sci U S A, 97, pp.291~296 (2000)
  28. Lovitch SB, "Amino-terminal flanking residues determine the conformation of a peptide-class II MHC complex", J Immunol, 176, pp.2958~2968 (2006)
  29. Ren D, "Construction of bioactive chimeric MHC class I tetramer by expression, purification of human-murine chimeric MHC heavy chain, beta(2)m as a fusion protein in Escherichia coli", Protein Expr Purif, 50, pp.171~178 (2006)
  30. Brand DD, "Collageninduced arthritis", Nat Protoc, 2, pp.1269~1275 (2007)
  31. 박주원, "Establishment and characterization of bortezomib-resistant U266 cell line: Constitutive activation of NF-κB-mediated cell signals and", or alterations of ubiquitylation-related genes reduce bortezomib-induced apoptosis, 2014, pp.47(5), 274~279[DOI]

관련 논문AI추천

Recombinant Adeno-Associated Virus Expressing Truncated IK Cytokine Diminishes the Symptoms of Inflammatory Arthritis김은경, 남재환, 박혜림, 조미라, 최슬기, Marstella Minelko한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2017 · 제27권 제10호제2형 콜라겐 경구관용 유도 동물모델에서 수지상 세포의 Indoleamine 2,3-dioxygenase 의존성 관절염 항원 특이 T세포 증식반응 제어 연구김호연, 민소연, 민준기, 박경수, 박민정, 박성환, 윤종현, 조미라, 조영규대한면역학회 · Immune Network2005 · 제5권 제4호Role of Citrullinated Fibrinogen Peptides in the Activation of CD4 T Cells from Patients with Rheumatoid Arthritis신기혁, 심승철, 이승효, 임미경, 주지현, 홍석찬, Eun-Hye Choi대한면역학회 · Immune Network2013 · 제13권 제4호Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside배용수, Md. Selim Ahmed대한면역학회 · Immune Network2016 · 제16권 제1호Deficiency of Foxp3^+ Regulatory T Cells Exacerbates Autoimmune Arthritis by Altering the Synovial Proportions of CD4^+ T Cells and Dendritic Cells오혜좌, 윤지희, 장은경, 조미라대한면역학회 · Immune Network2011 · 제11권 제5호콜라겐 유도 관절염에서 콜라겐 항원 특이 V?3+CD4+ T 세포의 선택적 증식김완욱, 김호연, 민소연, 민준기, 박성환, 윤종현, 이재선, 이정은, 조미라대한면역학회 · Immune Network2005 · 제5권 제2호

이 간행물의 다른 논문 (8건)